Pfizer Inc vs Powell Industries — how do they compare? Pfizer Inc trades at $27.88 (market cap $158.39B), while Powell Industries trades at $180.26 (market cap $6.65B). The key difference: Pfizer Inc is far larger — about 23.8× Powell Industries's market cap, and Pfizer Inc pays the higher dividend (6.19%). Which is the better fit depends on your goals.
| PFE | POWL | |
|---|---|---|
Market Cap | $158.39B | $6.65B |
Volume | 29,869,932 | — |
Sector | Health | Industrials |
52-Week High | $29.02 | $322.05 |
52-Week Low | $23.60 | $92.33 |
Enterprise Value | $209.89B | $6.02B |
Dividend Yield | 6.19% | 0.2% |
Signals from Pluang's Aura AI — not financial advice
Pfizer (PFE) trades at $27.78, down 2.36% today, with a consensus price target of $28.33 suggesting modest upside. The stock shows mixed technical signals with bullish moving averages but neutral oscillators. Recent earnings have consistently beaten expectations, though revenue declined from pandemic peaks. The company maintains strong cash flow generation and a solid dividend yield of approximately 3.1%.
Pfizer presents a value opportunity with reasonable valuation metrics and dividend stability, but faces headwinds from post-COVID revenue normalization and patent expirations. The company's pipeline progress in obesity and oncology could drive future growth, though execution risks remain. Analyst sentiment leans cautious with 59% hold ratings.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.
Read more on PFE →Powell Industries designs and manufactures electrical equipment and engineered solutions for power distribution and control. Its products are used across energy, utility, industrial, and commercial infrastructure.
Read more on POWL →